Sign in

CIK 0001576885 · <br>Emerging growth company

Acumen Pharmaceuticals, Inc.

Sign in to watch
Ticker
ABOS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364108129
Phone
617-344-4190
Business address
1210-1220 WASHINGTON STREET, SUITE 210, NEWTON, MA, 02465
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. CERT Other Certification
  9. CORRESP Other Correspondence Between Filers and SEC Staff
  10. CORRESP Other Correspondence Between Filers and SEC Staff
  11. 8-A12B Other Registration of Securities
  12. CORRESP Other Correspondence Between Filers and SEC Staff
  13. S-1/A Offering Registration Statement
  14. CORRESP Other Correspondence Between Filers and SEC Staff
  15. UPLOAD Other SEC-generated Letter
  16. CORRESP Other Correspondence Between Filers and SEC Staff
  17. S-1 Offering Registration Statement
  18. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  19. DRS/A Other Draft Registration Statement
  20. UPLOAD Other SEC-generated Letter

Page 18 of 19 · 365 filings